|
There were multiple 510k numbers reported to be involved.The information is as follows: g.4.Pma / 510(k)#: k982541.Investigation summary: bd received 25 samples and 2 photos for investigation.One of the customer photos displays the device packaging, while the other photo shows several devices with blood leakage in the holder.However, needle point integrity could not be evaluated from the photos, as the safety shields are covering the iv cannula.The 25 returned samples were visually inspected for cannula defects, including needle point integrity, and all samples passed testing with no evidence of damage or poor needle point integrity.Additionally, 10 returned samples were evaluated for lube coverage, and all samples exhibited sufficient lube coverage on the iv cannula.Furthermore, 10 returned samples underwent functional tests to assess device functionality, and all samples passed testing with no evidence of side pierced sleeves, poor sleeve recovery, or sleeve leakage.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint has been confirmed for the indicated failure mode sleeve leakage.This complaint is unable to be confirmed for the indicated failure mode: needle point integrity.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
|